T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.63 and traded as low as $0.10. T2 Biosystems shares last traded at $0.11, with a volume of 49,269 shares trading hands.
Analysts Set New Price Targets
Separately, StockNews.com started coverage on shares of T2 Biosystems in a research report on Thursday. They issued a “sell” rating for the company.
Read Our Latest Stock Report on T2 Biosystems
T2 Biosystems Stock Performance
About T2 Biosystems
T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
See Also
- Five stocks we like better than T2 Biosystems
- What Are Some of the Best Large-Cap Stocks to Buy?
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Consumer Discretionary Stocks Explained
- The 3 Most Talked About Investments on WallStreetBets Right Now
- P/E Ratio Calculation: How to Assess Stocks
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
